Holen Sie sich die Stockscreener-App
1.53
1.24%
-0.03
Nyxoah Sa Aktie (NYXH) Neueste Nachrichten
Gross profit of Nyxoah SA – HAM:5YI - TradingView
Price to book ratio of Nyxoah SA – HAM:5YI - TradingView
Nyxoah Begins U.S. Post-Approval Study of Genio Sleep Apnea Implant - finance.biggo.com
Cash per share of Nyxoah SA – HAM:5YI - TradingView
Nyxoah Stock Down Despite First Genio Implant in U.S. BREATHE Trial - Yahoo Finance
symbol__ Stock Quote Price and Forecast - cnn.com
Nyxoah Launches Major U.S. Post-Approval Study for Genio Sleep Apnea Device - TipRanks
A sleep apnea study will implant up to 229 patients and follow them for five years - Stock Titan
The trading volume of these stocks is deviating from the norm in today's session. - ChartMill
Nyxoah SA (NYXH) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Cantor Fitzgerald reiterates Nyxoah stock rating on trial success By Investing.com - Investing.com Canada
Cantor Fitzgerald reiterates Nyxoah stock rating on trial success - Investing.com
Nyxoah stock rises on pivotal trial win for Genio (NYXH:NASDAQ) - Seeking Alpha
Nyxoah stock surges as sleep apnea study hits endpoints By Investing.com - Investing.com India
NYXH Jumps As ACCCESS Trial Data Reset The Trading Map - timothysykes.com
NYXH Stock Jumps As ACCCESS Trial De‑Risks Sleep Apnea Bet - StocksToTrade
NYXH Stock Pops As ACCCESS Trial Data Fuels Breakout Hopes - timothysykes.com
NYXH Stock Jumps As ACCCESS Trial De-Risks U.S. Growth Story - StocksToTrade
87.7% improved on a measure of oxygen drops during sleep. No device-related serious adverse events were reported. - Stock Titan
Information on the total number of voting rights and shares - GlobeNewswire
Nyxoah (NYXH) Results Versus Estimates: The Available Earnings Metric Delivers a Miss in the Current Update; Market Reaction: The Share Price Sheds 2.74% in the Current UpdateEarnings Power Value - vinanet.vn
Nyxoah (NYXH) Latest: Falls 2.74% to $1.60 in Latest Trading; Price Context: the Current Price Sits Inside the Supplied Technical Range at the CloseIndex Put Call - vinanet.vn
Cantor Fitzgerald cuts Nyxoah stock price target on valuation By Investing.com - Investing.com Nigeria
Cantor Fitzgerald cuts Nyxoah stock price target on valuation - Investing.com
Cantor Fitzgerald Issues Pessimistic Forecast for Nyxoah (NASDAQ:NYXH) Stock Price - MarketBeat
NYXH Q2 2026 Earnings: EPS Miss of 46.48% Overshadowed by 2.53% Share GainCapex Guidance - vinanet.vn
Understanding Momentum Shifts in (NYXH) - Stock Traders Daily
Nyxoah (NASDAQ: NYXH) investors report 11.0M-share, 9.9% beneficial stake - Stock Titan
Nyxoah (NYXH) Q2 2026 Earnings: Wider-than-Expected Loss Flags Cost PressuresQuarterly Profit Report - dars.gov.et
Nyxoah SA (EBR:NYXH) Just Released Its Second-Quarter Earnings: Here's What Analysts Think - webull.com
Wall Street Zen Downgrades Nyxoah (NASDAQ:NYXH) to Sell - MarketBeat
A Quick Look at Today's Ratings for Nyxoah SA(NYXH.US), With a Forecast Between $2.31 to $6 - Moomoo
Nyxoah (NASDAQ:NYXH) Releases Earnings Results, Misses Expectations By $0.20 EPS - MarketBeat
Oppenheimer Adjusts Price Target on Nyxoah to $4 From $13, Maintains Outperform Rating - marketscreener.com
Nyxoah SA Stock 12‑Month Price Target Cut to $6, Implies 326% Upside - TradingView
Nyxoah SA Revenue Breakdown – EURONEXT:NYXH - TradingView
Piper Sandler Maintains Nyxoah SA(NYXH.US) With Buy Rating, Cuts Target Price to $6 - Moomoo
Nyxoah Q2 Earnings Call Highlights - MarketBeat
Nyxoah Reports Second Quarter and First Half 2026 Financial and Operating Results - The Manila Times
Nyxoah SA (NYXH) (Q2 2026) Earnings Call Highlights: US Revenue Surges 22% Sequentially, $110M ... - Yahoo Finance
Nyxoah SA reports results for the quarter ended June 30Earnings Summary - TradingView
Nyxoah SA (NYXHB.XD) Q2 FY2026 earnings call transcript - Yahoo Finance
NYXH: Q2 2026 revenue surged 21% sequentially, with strong U.S. growth and robust outlook - TradingView
Earnings To Watch: Nyxoah SA (XBRU:NYXH) Q2 2026 -- GF Value Sees 5209% Upside - GuruFocus
Avoiding Lag: Real-Time Signals in (NYXH) Movement - Stock Traders Daily
Nyxoah SA (NYXH) Holds at $1.45 as Sleep Apnea MedTech Stock Tests Key Support ZoneSuperTrend Flip - vinanet.vn
Nyxoah SA expected to post a loss of 42 cents a shareEarnings Preview - TradingView
NYXH Q1 2026 Earnings: Narrower-Than-Expected Loss Beats Estimates by 27%, Revenue Remains Undisclosed - vinanet.vn
Nyxoah (NYXH) Projected to Release Earnings on Wednesday - MarketBeat
Nyxoah management to discuss Q2 results in Aug. 5 webcast - Stock Titan
Nyxoah SA (NYXH) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Nyxoah SA (NYXH) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Nyxoah SA (NYXH) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Nyxoah to Release Second Quarter 2026 Financial Results on August 5, 2026 - GlobeNewswire
Nyxoah SA (NYXH) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
NYXH|Nyxoah SA|Price:1.400|Chg%:-0.070 - TradingKey
Nyxoah SA (NYXH) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Nyxoah (NYXH) Q1 2026 Earnings: EPS Surprise of 27% Despite Zero Revenue; Shares Dip 4.76%Earnings Beat Alert - po-news-eg.net
1.12%
1.05%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):